Skip to main content
. 2020 Aug 10;55(11):2913–2923. doi: 10.1002/ppul.24993

Table 1.

Group characteristics

Control Moderate Severe
HR Baseline 142 ± 6 164 ± 9 177 ± 9*
Post Tx 145 ± 7 192 ± 18 227 ± 26*
Stable 150 ± 5 205 ± 13 236 ± 21**
MBP Baseline 80.8 ± 3.4 69.5 ± 4.4 84.5 ± 5.6
Post Tx 78.3 ± 2.1 68.4 ± 4.8 64.7 ± 7.2
Stable 75.2 ± 3.9 68.8 ± 6.5 53.4 ± 5.6*
CVP Baseline 8.8 ± 0.2 10.0 ± 1.1 8.2 ± 0.4
Post Tx 8.8 ± 0.2 10.2 ± 1.5 7.0 ± 1.1
Stable 9.0 ± 0.58 9.0 ± 0.84 8.0 ± 0.71

Note: Heart rate (HR, bpm), mean blood pressure (MBP, mm Hg), and central venous pressure (CVP) measured at baseline, 1 h posttreatment and at the stabilized timepoint at end of study, represented as mean ± SE for each group (N = 5).

*

P  < .05;

**

P  < .01 compared with the control group.